Clinical trial

The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

NCT06494878

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Aspirin Normalized identity: aspirinView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Low-molecular-weight heparin Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-06-04

PhasePHASE3

Conditions

Venous Thromboembolismverified · MONDO: venous thromboembolism

Postpartum Periodunresolved

Aspirinunresolved

Low Molecular Weight Heparinunresolved

Interventions

AspirinDRUG · verified · RxNorm: aspirin

Low-molecular-weight heparinDRUG

Sponsors & collaborators

University of Calgarylead sponsor

Canadian Institutes of Health Research (CIHR)collaborator

European Clinical Research Infrastructure Networkcollaborator

Mapped research locations

DublinIreland2 ParisFrance1 WarsawPoland1 ToulouseFrance1 BrusselsBelgium1 OttawaOntario, Canada1 CalgaryAlberta, Canada1 AmsterdamNetherlands1 NancyFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06494878 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.